Phase 2 Pericarditis Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Transition to KPL-387 Monotherapy Dosing & Administration Study
PericarditisHeart DiseasesRecurrent Pericarditis
Kiniksa Pharmaceuticals International, plc80 enrolled23 locationsNCT07288216
Recruiting
Phase 2Phase 3
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
PericarditisRecurrent PericarditisPericarditis Acute
Kiniksa Pharmaceuticals International, plc165 enrolled56 locationsNCT07010159
Recruiting
Phase 2
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
Recurrent Pericarditis
Zomagen Biosciences Ltd.50 enrolled17 locationsNCT06836232
Recruiting
Phase 2
High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Tuberculous PericarditisHIV Status
University of Cape Town60 enrolled2 locationsNCT04521803